U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07646691) titled 'An Observational Study Into Antimicrobial Resistance in Patients With a Chronic Lung Disease' on June 09.
Brief Summary: Antimicrobial resistance (AMR) refers to the ability of microorganisms like bacteria, viruses, fungi and parasites to resist the effects of antimicrobial drugs (such as antibiotics) which are widely used as treatment. AMR poses an escalating global health threat, contributing to difficult-to-treat infections associated with increased disease spread, disability and death, as well as a substantial economic burden.
In chronic lung diseases, such as bronchiectasis, Cystic fibrosis or chronic obstructive lung disease ...